Tusamitamab ravtansine Antibody
Tusamitamab ravtansine is an antibody-drug conjugate (ADC) targeting CEACAM5, delivering the cytotoxic maytansinoid DM4 to antigen-expressing tumor cells. It is a research tool for studying ADC mechanisms and targeted therapy in CEACAM5-positive cancers, with applications in both in vitro and in vivo preclinical models.
Product Specifications
Target
Antibody-Drug Conjugates (ADCs), Microtubule Associated
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog